Enveda Raises $311 Million in Series E Round
AI-driven natural-medicine biotech Enveda has raised $311 million in a Series E round, one of the larger late-stage biotech financings of the year.
Section
AI-driven natural-medicine biotech Enveda has raised $311 million in a Series E round, one of the larger late-stage biotech financings of the year.
HIFI raised $37 million and Atum secured $13.5 million in new venture rounds, per Crypto News — over $50 million in fresh crypto…
Indian startups pulled in over $203 million this week, with EV maker Ultraviolette Automotive and spacetech firm GalaxEye among t…
Anthropic has not filed to go public, but informal secondary trades are already valuing the AI company near a trillion dollars, Y…
SK Hynix, the world's No. 2 memory chipmaker, has formed a dedicated venture capital arm focused on artificial intelligence, exte…
OpenAI investors have approached the company about a new funding round, CNBC reports, as backers move to fund the ChatGPT maker's…
Priority Technology's CEO buys his own company at a 65% premium; Vitruvian leads a $600M Angle Health tender; Fed hike pushes buy…
Bengaluru-based Dextr AI raised $6.7M in seed funding led by Elevation Capital. Its AI agents process over one million monthly in…
Cyera raised $400 million from Goldman Sachs, the largest of eight New York City venture deals tracked by The Business Journals t…
Invest Qatar, LG NOVA and Aurion Capital signed an agreement to expand technology investment and venture building across MENA, Pu…
Island and Cyera each raised $400M in Evolution Equity-led rounds, topping a $2.3B week of U.S. megadeals spanning AI, biotech, n…